David Kirske Sells 60,000 Shares of CTI BioPharma Corp. (NASDAQ:CTIC) Stock

CTI BioPharma Corp. (NASDAQ:CTIC – Get Rating) CFO David Kirske sold 60,000 shares of the firm’s stock in a transaction dated Friday, June 17th. The stock was sold at an average price of $6.21, for a total transaction of $372,600.00. Following the completion of the transaction, the chief financial officer now directly owns 7,397 shares […]

Related Keywords

United States ,David Kirske ,Geode Capital Management ,Securities Exchange Commission ,Stonepine Capital Management ,Cti Biopharma Corp ,Biopharma Corp ,Nasdaq ,Needham Company ,Kennedy Capital Management Inc ,Biopharma Company Profile Get Rating ,Get Rating ,Exchange Commission ,Capital Acquisition ,Capital Management ,Lion Point Capital ,Pharma Company Profile ,Pharma Corp ,Cti Biopharma ,Nasdaq Ctic ,Arctic ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,